Atavistik Bio Raises $60m For Metabolic Disease, Cancer Drug Discovery

Acting CEO Comes From Peloton; President/CSO From Blueprint, Agios

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.